T opical steroids are widely used by dermatolog g gists and other physicians to treat skin diseasg g es. Although mostly useful, these medications are not without risks, especially when abused or overg g used by patients or parents. We report the case of an ing g fant who developed Cushing syndrome due to clobetag g sol propionate 0.05% (Dermovate, GlaxoSmithKline) ointment used by his mother to treat diaper psoriasis.
CASE
An 11 monthgold Saudi boy was referred to our care in the dermatology clinic because of resistant diaper eruption since the age of 4 months. At this age, the mother consulted a local pharmacist and she was disg g pensed clobetasol propionate 0.05% (Dermovate) ointg g ment, which was used liberally albeit intermittently for 7 months. On examination, the child was cushingoid with moon face and had hypertrichosis on sideburns ( Figure 1 ) with a bodyweight above the 95th centile and height at the 95th centile. Blood pressure was normal. Examination of the diaper area revealed sharply demarg g cated bright red plaques involving both inguinal folds and adjoining parts of both upper thighs (Figure 2 ). Multiple linear stretch marks were seen in both groin folds. The rest of the examination was normal. The diagnosis was infantile diaper psoriasis in addition to iatrogenic Cushing syndrome induced by exogenous topical steroids. This was supported by an undetectable basal morning cortisol level (<5 nmol/L). Maintenance oral hydrocortisone was not started, but was recomg g mended during acute infections until complete recovery of adrenal function. Because of a diaper psoriasis flare when Dermovate ointment was discontinued a few days previously by the referring physician, the mother was instructed to use topical 1% hydrocortisone and micong g azole combination cream (Daktacort, JanssengCilag) in addition to pimecrolimus (Elidel, Novartis) cream sparg g ingly only when redness appeared and to discontinue when redness disappeared. Generous use of emollient was maintained at all times. On review 8 weeks later, his cushingoid features were regressing and his basal morning cortisol concentration has normalized to 259 nmol/L. The diaper psoriasis had cleared and was maintained under control with Daktacort and Elidel creams use as needed whenever active.
DISCUSSION
The therapeutic use of the antiginflammatory properg g ties of glucocorticoid compounds including topical preparations is widely practiced for different indicag g tions including skin diseases. While mostly useful, steg g roids have the potential to cause side effects including iatrogenic Cushing syndrome.
1 In the majority of cases this results from oral or parenteral administration, but topical application of potent topical steroids can induce Cushing syndrome, as well as the suppression of the hyg g pothalamicgpituitarygadrenal (HPA) axis.
Topical steroids are available in different vehicles such as ointments, creams, and lotions with ointments being the most potent preparation for any particular compound. Topical steroid potency is variable and ranges from low potency to superpotent with clobetag g sol propionate 0.05% (Dermovate) being the most pog g tent topical steroid available. The lack of awareness of side effects of topical steroids and the underestimation of their adverse effects can result in severe and even catg g astrophic consequences. Frequently, patients and parg g ents of children have little or no reservation to obtain and use them, without prescription, from pharmacies or even friends and relatives.
Systemic absorption of topical steroids are known to ocg g cur; there are many reports of such occurrences.
1g3 Children can absorb a proportionally larger amount of topical steg g roids because of the higher body surface areagtogweight ratio.
2 In addition, other factors may enhance the abg g sorption of topically applied steroids. These include thin skin as in the eyelids or occlusion as seen in body folds, including the diaper area. Side effects of topical steroids can range from local to systemic. Local effects include skin atrophy, telangiectasia, striae, hypertrig g chosis and increased cutaneous infections. Systemic adverse effects include the suppression of the HPA axis and potentially all other known adverse effects of sysg g temic steroids including osteoporosis, obesity, hyperg g tension, cataracts and cushingoid features. Cushing syndrome refers to a group of signs and symptoms that develop as a result of either endogenous overproduction or exogenous treatment with adrenal corticotropin hormone (ACTH) or hydrocortisone and its analogs. Cushing syndrome usually presents ing g sidiously with growth failure, generalized obesity, and a rounded face with prominent cheeks and flushed apg g pearance, which is referred to as a moon face. Centripetal fat accumulation leads to buffalo hump. Cutaneous stigmata of steroid overuse may also be apparent as facial acne, striae and hypertrichosis. The complete blood count may reveal the presence of polycythemia, lymphopenia and eosinophilia. Serum electrolytes are 3. Abma eM, Blanken r, de heide LJM. Cushing's syndrome caused by topical steroid therapy for psoriasis. the Journal of Medicine. 2002; 60:148-50. usually normal but hypokalemia may be seen with or without hyperglycemia. A more specific test to docug g ment Cushing syndrome should be done based on the possible etiology. Exogenous glucocorticoid intake can be suspected by careful history and then confirmed by low levels of plasma ACTH, morning serum cortisol, and 24ghour free urinary cortisol excretion.
To avoid side effects of topical steroids many meag g sures must be implemented, particularly in children. First, a correct diagnosis must be established to confirm the responsiveness to topical steroids. Second, steroidg sparing measures must always be implemented, if posg g sible, to minimize topical steroid consumption. These include emollients and other agents. For psoriasis these include a topical vitamin D analog like calcipotriol and topical calcineurin inhibitors like pimecrolimus. In adg g dition, a minimally potent preparation should always be used whenever possible. Only preparations containg g ing 1% hydrocortisone acetate are allowed on the face, genitalia and body folds for most indications. Lastly, short courses with drug holidays in between should be encouraged to allow for skin recovery and remodeling.
In conclusion, we report an infant with diaper psog g riasis who developed Cushing syndrome due to the abuse of topical steroid ointment. This case emphag g sizes that topical steroids are useful, but they are not without risks. Judicious use is needed to avoid their side effects.
